Psilocybin Pharmaceutical Combination Therapies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

PharmaTher Announces Sale of Psilocybin Program
Newscope Capital Corporation who through its wholly-owned subsidiary, PharmaTher Inc. is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals, is pleased to announce that, further to its press release dated December 21, 2020, it has entered into an asset purchase agreement with Revive Therapeutics Ltd. to sell the full rights to PharmaTher’s intellectual property …
Newscope Capital Corporation (CSE: PHRM) (OTCQB: PHRRF), who through its wholly-owned subsidiary, PharmaTher Inc. (“PharmaTher” or the “Company”), is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals, is pleased to announce that, further to its press release dated December 21, 2020, it has entered into an asset purchase agreement (the “Agreement”) with Revive Therapeutics Ltd. (“Revive”) (CSE: RVV, USA: RVVTF) to sell the full rights to Pha ....

United States , Michael Frank , Fabio Chianelli , Therapeutics Ltd , Pharmather Inc , Drug Administration , Trademark Office , National Health Research Institutes , Newscope Capital Corporation , Neither The Canadian Securities Exchange , Regulation Services Provider , Revive Therapeutics , Purchase Price , Acquired Assets , Neurological Brain Injury , United States Provisional Application Serial , Liver Carcinoma , Breast Neoplasms , Kidney Neoplasms , Acute Myeloid , Psilocybin Pharmaceutical Combination Therapies , Mother Inc , Canadian Securities Exchange , ஒன்றுபட்டது மாநிலங்களில் , மைக்கேல் வெளிப்படையான , சிகிச்சை லிமிடெட் ,